[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627165":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":10,"responsibleParty":30,"collaborators":10,"id":32,"slug":33,"hasResults":34,"nctId":35,"briefTitle":36,"officialTitle":37,"acronym":10,"eligibilityCriteria":38,"healthyVolunteers":34,"sex":39,"minAge":40,"maxAge":10,"enrollmentInfo":41,"targetDuration":10,"studyType":44,"phases":10,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":10},{"fullName":5,"class":6},"Takeda","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"All Participants",null,"Adolescent and adult participants diagnosed with HAE who are receiving Takhzyro or initiating Takhzyro treatment for the first time in routine clinical practice will be included. Both retrospective and prospective data will be collected for up to 6 years. Treatment and follow-up will be determined by the treating physicians according to routine clinical practice.",[13],"Other: No intervention",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"OTHER","No intervention","This is a non-interventional study.",[9],[21],{"name":22,"affiliation":5,"role":23},"Study Director","STUDY_DIRECTOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Takeda Contact","CONTACT","+1-877-825-3327","medinfoUS@takeda.com",{"type":31,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100627165","a-study-of-takhzyro-in-teenagers-and-adults-with-hereditary-angioedema-hae-in-south-korea-100627165",false,"NCT07445087","A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea","A Post Marketing Surveillance Study (Usage Results Study) for Takhzyro in South Korea","Inclusion criteria:\n\n1. Participants aged 12 years or older at time of initiation of Takhzyro.\n2. Participants who are treated or will be treated with Takhzyro according to the approved label of South Korea.\n3. The participant or legally authorized representative agrees to participate.\n\nExclusion criteria:\n\n1. Any of the contraindications included in the Prescribing Information (PI) for TAKHZYRO apply.\n2. Participant is currently enrolled in an interventional trial.","ALL","12 Years",{"count":42,"type":43},35,"ESTIMATED","OBSERVATIONAL","Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care.\n\nThe treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.",[47],"Hereditary Angioedema (HAE)",[49],"Drug Therapy","NOT_YET_RECRUITING","2026-06-17",{"date":53,"type":54},"2026-06-18","ACTUAL",{"date":56,"type":43},"2026-10-01",{"date":58,"type":43},"2032-02-29",{"name":5,"class":6}]